The tyrosine kinase antagonist imatinib mesylate
Heinzl, S.
Medizinische Monatsschrift für Pharmazeuten 25(1): 4-7
2002
ISSN/ISBN: 0342-9601 PMID: 11826665 Document Number: 548608
Document emailed within 1 workday
Related Documents
Scheinfeld, N. 2006: Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate Journal of Drugs in Dermatology: Jdd 5(3): 228-231Nagar, B. 2007: c-Abl tyrosine kinase and inhibition by the cancer drug imatinib (Gleevec/STI-571) Journal of Nutrition 137(6 Suppl 1): 1518s-1523s; Discussion 1548s
Gelderblom, H.; Hogendoorn, P.C.; van der Graaf, W.T.; Verweij, J. 2003: Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor Nederlands Tijdschrift Voor Geneeskunde 147(42): 2051-2055
Verstappen, M.C.H.M.; Mattijssen, V.; van der Reijden, B.A.; van der Heijden, A.J.P.; Wahab, P.J.; de Vries, R.A. 2006: A man with oral ulcers caused by hypereosinophilic syndrome and a good response to the tyrosine-kinase inhibitor imatinib Nederlands Tijdschrift Voor Geneeskunde 150(21): 1188-1192
Wong, M.; Sade, S.; Gilbert, M.; Klieb, H.B.E. 2011: Oral melanosis after tyrosine kinase inhibition with Imatinib for chronic myelogenous leukemia: report of a case and review of the literature Dermatology Online Journal 17(5): 4
Bhatia, R.; Munthe, H.A.; Verfaillie, C.M. 1998: Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors Leukemia 12(11): 1708-1717
Zhu, J.-h.; Li, Q.-w.; Xiao, W.-h.; Sun, J.-z.; Wang, R.-l.; Lu, J.-y. 2011: Advanced dermatofibrosarcoma protuberans treated with imatinib mesylate Zhonghua Zhong Liu Za Zhi 33(6): 470-472
Durosinmi, M.A.; Ogbe, P.O.; Salawu, L.; Oyekunle, A.A. 2007: Herpes zoster complicating imatinib mesylate for gastrointestinal stromal tumour Singapore Medical Journal 48(1): e16-e18
Deshmukh, C.; Saikia, T.; Bakshi, A.; Amare-Kadam, P.; Baisane, C.; Parikh, P. 2005: Imatinib mesylate in chronic myeloid leukemia: a prospective, single arm, non-randomized study Journal of the Association of Physicians of India 53: 291-295
Shen, K.-t.; Hou, Y.-y.; Qin, X.-y.; Song, L.-j.; Sujie, A. 2005: Imatinib mesylate STI571 therapy for five patients with advanced gastrointestinal stromal tumors Zhonghua Wei Chang Wai Ke Za Zhi 8(2): 129-131
Ioannou, M.; Demertzis, N.; Iakovidou, I.; Kottakis, S. 2007: The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors Anticancer Research 27(2): 1143-1147
Hinchcliff, M.; Huang, C.-C.; Ishida, W.; Fang, F.; Lee, J.; Jafari, N.; Wilkes, M.; Bhattacharyya, S.; Leof, E.; Varga, J. 2012: Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro Clinical and Experimental Rheumatology 30(2 Suppl 71: S86-S96
Pectasides, D.; Nikolaou, M.; Pectasides, E.; Koumarianou, A.; Valavanis, C.; Economopoulos, T. 2008: Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma Anticancer Research 28(4c): 2317-2320
Feki, J.; Marrekchi, G.; Boudawara, T.; Rekik, N.; Maatouq, S.; Boudawara, Z.; Frikha, M. 2015: Subdural hematoma during therapy of gastro-intestinal stromal tumor (GIST) with Imatinib mesylate Gulf Journal of Oncology 1(17): 92-95
Ferraresi, V.; Catricalà, C.; Ciccarese, M.; Ferrari, A.; Zeuli, M.; Cognetti, F. 2006: Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate Anticancer Research 26(6c): 4771-4774
Bar-Sela, G.; Lev, L.M.; Kuten, A.; Wollner, M.; Haim, N. 2006: Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients Harefuah 145(1): 2-7 80
Okuda, H.; Tanaka, H.; Ueno, M.; Shitani, M.; Nasuno, M.; Suzuki, C.; Nishimura, S.; Kimura, H.; Yonezawa, K.; Abe, T.; Yoshida, Y.; Kawabata, M. 2005: A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(12): 1941-1944
Gelibter, A.; Milella, M.; Ceribelli, A.; Zeuli, M.; Ferraresi, V.; Vecchione, A.; Cognetti, F. 2004: PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients Anticancer Research 24(5b): 3147-3151
Nakashima, S.; Fujita, Y.; Matsuo, H.; Ariyoshi, Y.; Fukuda, K.; Fujiyama, J.; Masuyama, M. 2012: Two cases of surgical resection of rectal gastrointestinal stromal tumor after neoadjuvant therapy with imatinib mesylate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 1932-1934
Sung, Y.; Kim, M.Hee.; Cho, E. 2019: Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate Journal of Cosmetic and Laser Therapy 21(4): 243-244